Estamos no ar no ! Saiba mais
ícone de HEAL

Global X Funds Global X HealthTech ETF

29,65 USD
-0,72
2,37%
No fechamento Atualizado 16 de out. 16:00 EDT
1 dia
-2,37%
5 dias
-0,44%
1 mês
2,56%
3 meses
5,37%
6 meses
14,88%
No acumulado do ano
1,19%
1 ano
-8,68%
5 anos
-44,26%
10 anos
-36,52%

Notícias

Positivo
Neutro
Negativo
Sentimento 3 meses
Positivo 0%
Neutro 0%
Negativo 0%
Neutro
Newsfile Corp
há 4 meses
Restart Life Advances AI-Driven E-Commerce Strategy to Scale Online Sales Growth for Holy Crap Foods
Vancouver, British Columbia--(Newsfile Corp. - June 18, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its wholly owned subsidiary, Holy Crap Foods Inc., is preparing to begin harnessing predictive AI to further its e-commerce consumer and wholesale sales platform. The initiative is engineered to leverage readily available predictive consumer behavior models to optimize, monetize, and scale the brand's direct-to-consumer and business-to-business reach.
Restart Life Advances AI-Driven E-Commerce Strategy to Scale Online Sales Growth for Holy Crap Foods
Neutro
Seeking Alpha
há 5 meses
Medical Technology Stocks: Innovation Endures As Valuations Reset
Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.
Medical Technology Stocks: Innovation Endures As Valuations Reset
Positivo
Seeking Alpha
há 11 meses
Investing In Health Stocks - How Policy Clarity Is Opening Doors
The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.
Investing In Health Stocks - How Policy Clarity Is Opening Doors
Negativo
Benzinga
ano passado
Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs
The U.S. Food and Drug Administration's recent enforcement action against drug promotion is sending ETFs with exposure to weight-loss treatment manufacturers into question.
Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs
Neutro
Seeking Alpha
ano passado
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Neutro
Zacks Investment Research
ano passado
The Zacks Analyst Blog Doximity, Omnicell, Embecta, Cencora and EDOC
Doximity, Omnicell, Embecta, Cencora and EDOC are included in this Analyst Blog.
The Zacks Analyst Blog Doximity, Omnicell, Embecta, Cencora and EDOC
Neutro
InvestorPlace
há 2 anos
3 Telemedicine Stocks Poised for Possible Healthcare Evolution
Telemedicine stocks could do no wrong during the pandemic. With millions on lockdown and still in need of medical care, telemedicine stocks, like Teledoc Health (NYSE:TDOC) ranfrom about $80 to a high of $288.80.
3 Telemedicine Stocks Poised for Possible Healthcare Evolution
Positivo
InvestorPlace
há 2 anos
3 Stocks That Could Benefit from the Rise of Telemedicine
With the growing demand for telemedicine, the market could be worth about $450 billion by the time 2032 rolls around. That's according to Emergen Research.
Neutro
ETF Trends
há 2 anos
VettaFi Voices On: Accessing Disruptive Innovation
Good Morning, VettaFi Voices! Disruptive innovation is a popular topic, and it encompasses everything from bitcoin and cryptocurrency to electric vehicles to artificial intelligence.
Gráficos de preços implementados com Lightweight Charts™